A Prospective Pilot Study of Cardiac MRI (cMRI) for Evaluation of Early Cardiac Toxicity in Patients Receiving Neoadjuvant Chemoradiotherapy (nCRT) for Esophageal Cancer
Muhammad Shuja, Christopher L. Hallemeier(Mayo Clinic in Arizona), Cameron M. Callaghan(Mayo Clinic in Arizona), A. Bratt, Roman O. Kowalchuk(Mayo Clinic in Arizona), Michael G. Haddock(Mayo Clinic in Arizona), Apurva Challa, Krishan R. Jethwa(Mayo Clinic), Phillip M. Young(Mayo Clinic), Kenneth W. Merrell(Mayo Clinic), W. Breen, W.S. Harmsen(Mayo Clinic), Jeremy D. Collins(Mayo Clinic)
International Journal of Radiation Oncology*Biology*Physics
September 27, 2024
Cited by 0
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)
|Journal of Clinical Oncology|2008|270
Oesophageal cancer
|The Lancet|2024|265